Physical activity is important for cardiovascular health and cardiorespiratory fitness in patients with psoriasis

por Auker, L., Cordingley, L., Griffiths, C. E. M., Young, H. S.
Publicado 2021

What are the barriers to physical activity in patients with chronic plaque psoriasis?

por Auker, L., Cordingley, L., Pye, S.R., Griffiths, C.E.M., Young, H.S.
Publicado 2020

Twelve‐week secukinumab treatment is consistently efficacious for moderate‐to‐severe psoriasis regardless of prior biologic and non‐biologic systemic treatment: Post hoc analysis o...

por Hampton, P., Halliday, A., Aassi, M., Subramanian, S., Jain, M., Griffiths, C.E.M.
Publicado 2021

Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis

por Thorneloe, R.J., Bundy, C., Griffiths, C.E.M., Ashcroft, D.M., Cordingley, L.
Publicado 2016

The top 10 research priorities for psoriasis in the U.K.: results of a James Lind Alliance psoriasis Priority Setting Partnership

por Majeed‐Ariss, R., McPhee, M., McAteer, H., Griffiths, C.E.M., Young, H.
Publicado 2019

Genetic interaction between placental growth factor and vascular endothelial growth factor A in psoriasis

por Young, H. S., Kamaly‐Asl, I. D., Laws, P. M., Pemberton, P., Griffiths, C. E. M.
Publicado 2019

‘Mind the gap’: what patients and clinicians believe is ‘unknown’ about psoriasis

por Majeed‐Ariss, R., McPhee, M., McAteer, H., Griffiths, C.E.M., Young, H.S.
Publicado 2020

No impairment of monocyte-derived Langerhans cell phenotype or function in early-onset psoriasis

por Shaw, F L, Kimber, I, Begum, R, Cumberbatch, M, Dearman, R J, Griffiths, C E M
Publicado 2012

Incidence, prevalence and mortality of patients with psoriasis: a U.K. population‐based cohort study

por Springate, D.A., Parisi, R., Kontopantelis, E., Reeves, D., Griffiths, C.E.M., Ashcroft, D.M.
Publicado 2016

Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta‐analysis of randomized controlled trials

por Rungapiromnan, W., Yiu, Z.Z.N., Warren, R.B., Griffiths, C.E.M., Ashcroft, D.M.
Publicado 2017

Aged human skin accumulates mast cells with altered functionality that localize to macrophages and vasoactive intestinal peptide‐positive nerve fibres

por Pilkington, S.M., Barron, M.J., Watson, R.E.B., Griffiths, C.E.M., Bulfone‐Paus, S.
Publicado 2018

Multiple switches between GP2015, an etanercept biosimilar, with originator product do not impact efficacy, safety and immunogenicity in patients with chronic plaque‐type psoriasis...

por Gerdes, S., Thaçi, D., Griffiths, C.E.M., Arenberger, P., Poetzl, J., Wuerth, G., Afonso, M., Woehling, H.
Publicado 2017

Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: randomized, controlled PSO‐ABLE study

por Paul, C., Stein Gold, L., Cambazard, F., Kalb, R.E., Lowson, D., Bang, B., Griffiths, C.E.M.
Publicado 2016

A novel mutation in IL36RN underpins childhood pustular dermatosis

por Ellingford, J.M., Black, G.C.M., Clayton, T.H., Judge, M., Griffiths, C.E.M., Warren, R.B.
Publicado 2015

The global state of psoriasis disease epidemiology: a workshop report

por Griffiths, C.E.M., van der Walt, J.M., Ashcroft, D.M., Flohr, C., Naldi, L., Nijsten, T., Augustin, M.
Publicado 2017

Effect of tofacitinib withdrawal and re‐treatment on patient‐reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis

por Griffiths, C.E.M., Vender, R., Sofen, H., Kircik, L., Tan, H., Rottinghaus, S.T., Bachinsky, M., Mallbris, L., Mamolo, C.
Publicado 2016

Risk of COVID‐19 infection in adult patients with atopic eczema and psoriasis: a single‐centre cross‐sectional study

por Yiu, Z.Z.N., Harding‐Oredugba, G., Griffiths, C.E.M., Warren, R.B., McMullen, E., Hunter, H.J.A.
Publicado 2021

Patient‐reported symptoms and signs of moderate‐to‐severe psoriasis treated with guselkumab or adalimumab: results from the randomized VOYAGE 1 trial

por Papp, K.A., Blauvelt, A., Kimball, A.B., Han, C., Randazzo, B., Wasfi, Y., Shen, Y.‐K., Li, S., Griffiths, C.E.M.
Publicado 2018

The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository

por Lecaros, C., Dunstan, J., Villena, F., Ashcroft, D. M., Parisi, R., Griffiths, C. E. M., Härtel, S., Maul, J. T., De la Cruz, C.
Publicado 2021

‘New to me’: changing patient understanding of psoriasis and identifying mechanisms of change. The Pso Well(®) patient materials mixed‐methods feasibility study

por Nelson, P.A., Kane, K., Pearce, C.J., Bundy, C., Chisholm, A., Hilton, R., Thorneloe, R., Young, H., Griffiths, C.E.M., Cordingley, L.
Publicado 2017